SCHEMBL1629709

SCHEMBL1629709

O=C(Cc1ccccc1)Nc1ccccc1-n1nccc1-c1ccc(O)cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 9/20 0.51
KMT2A Q03164 3/20 0.51
GAA P10253 2/20 0.51
PKM P14618 1/20 0.51
ALDH1A1 P00352 5/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
TSHR P16473 3/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPK10 P53779 1/20 0.43
HPGD P15428 2/20 0.42
HCAR2 Q8TDS4 1/20 0.42
MEN1 O00255 1/20 0.42
KDM4E B2RXH2 1/20 0.42
DEGS1 O15121 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629695 0.85 ALDH1A1 (0.47) KCNQ2KMT2AGAAPKMALDH1A1
SCHEMBL1629175 0.84 TYR (0.48) ALDH1A1TSHRLMNASMN1; SMN2MAPT
SCHEMBL1630414 0.83 KDM4E (0.51) KMT2AALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL12722777 0.81 ALDH1A1 (0.55) KCNQ2KMT2APKMALDH1A1LMNA
SCHEMBL1630352 0.80 HDAC1 (0.45) KMT2AALDH1A1LMNAHTTNPSR1
SCHEMBL1629234 0.78 HDAC1 (0.50) ALDH1A1TSHRSMN1; SMN2MAPTHTT
SCHEMBL1630006 0.77 MAPT (0.45) KMT2AGAAALDH1A1TSHRMAPT
SCHEMBL1630386 0.75 HSP90AA1 (0.51)
SCHEMBL1631545 0.75 HSP90AA1 (0.47) KMT2A
SCHEMBL15049763 0.74 HSP90AA1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P KCNQ2 3312/4885KMT2A 4362/4885GAA 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.